Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.
about
Alternative splicing of the human cytomegalovirus major immediate-early genes affects infectious-virus replication and control of cellular cyclin-dependent kinase.Mutation of glutamine to arginine at position 548 of IE2 86 in human cytomegalovirus leads to decreased expression of IE2 40, IE2 60, UL83, and UL84 and increased transcription of US8-9 and US29-32.An endogenous accelerator for viral gene expression confers a fitness advantage.Two Polypyrimidine Tracts in Intron 4 of the Major Immediate Early Gene Are Critical for Gene Expression Switching from IE1 to IE2 and for Replication of Human CytomegalovirusHuman cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus.Analysis of essential viral gene functions after highly efficient adenofection of cells with cloned human cytomegalovirus genomes.Coordination of late gene transcription of human cytomegalovirus with viral DNA synthesis: recombinant viruses as potential therapeutic vaccine candidates.Human cytomegalovirus IE2 86 and IE2 40 proteins differentially regulate UL84 protein expression posttranscriptionally in the absence of other viral gene products.Internal deletions of IE2 86 and loss of the late IE2 60 and IE2 40 proteins encoded by human cytomegalovirus affect the levels of UL84 protein but not the amount of UL84 mRNA or the loading and distribution of the mRNA on polysomesFate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.Human cytomegalovirus early protein pUL21a promotes efficient viral DNA synthesis and the late accumulation of immediate-early transcripts.Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.Conditional and reversible disruption of essential herpesvirus proteins.
P2860
Q34485281-581E9671-1921-4918-AA48-06D3963C41B8Q35362716-FD1F5952-9AE6-4AE1-9078-E46ADA51B3FCQ36555148-D322D8E6-C2A6-465C-8F75-38E70FBAFEB4Q37174468-4199629E-B8F4-423D-B173-5408D5D8915BQ37252826-4E80FC0C-9835-4905-969A-4002B2DED485Q37566765-3FFE96D9-9B75-48C3-986B-C7494FBDECCBQ38066570-96360C8C-29A6-40AE-89F6-193BD47C8B35Q39732633-6AC62C2E-2A64-484A-ACF2-4C3F5B1503B4Q39940804-E5E823CB-549A-4312-BB15-BADEDD99889DQ40086009-1A754C42-2383-4722-8EED-5319DA426A08Q42166179-2ADF8E2A-CE55-43A9-8A72-22CC059107BCQ42231391-202A9B11-EA8E-46BE-9289-6762D23B3E5CQ52594500-46CB82DE-88DE-4E8C-B970-577825FD5609
P2860
Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Development of cell lines that ...... nonviable IE2 mutant viruses.
@en
Development of cell lines that ...... nonviable IE2 mutant viruses.
@nl
type
label
Development of cell lines that ...... nonviable IE2 mutant viruses.
@en
Development of cell lines that ...... nonviable IE2 mutant viruses.
@nl
prefLabel
Development of cell lines that ...... nonviable IE2 mutant viruses.
@en
Development of cell lines that ...... nonviable IE2 mutant viruses.
@nl
P2093
P2860
P356
P1433
P1476
Development of cell lines that ...... nonviable IE2 mutant viruses.
@en
P2093
Charles L Clark
Christopher S Morello
Deborah H Spector
Rebecca L Sanders
P2860
P304
P356
10.1128/JVI.00675-08
P407
P577
2008-05-07T00:00:00Z